TNYA: Tenaya Therapeutics, Inc. Stock

by  •  • Comments Off on TNYA: Tenaya Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) n/a
Book Value ($M) 119.40
Book Value / Share n/a
Price / Book n/a
NCAV ($M) 69.93
NCAV / Share n/a
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -0.80
Return on Assets (ROA) -0.57
Return on Equity (ROE) -0.67

Liquidity (mrq)
Quick Ratio 6.68
Current Ratio 6.68

Balance Sheet (mrq) ($M)
Current Assets 94.48
Assets 143.95
Liabilities 24.56
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -115.95
Net Income -111.13

Cash Flow Statement (mra) ($M)
Cash From Operations -90.50
Cash from Investing 1.13
Cash from Financing 47.75

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
2 days ago 13G Empery Asset Management, LP 9.96
03-07 13D/A Column Group Iii, Lp 32.00 262.62
03-07 13D/A Casdin Capital, LLC 4.30 4.76
03-06 13G/A Jpmorgan Chase & Co 2.80 -55.69
02-14 13G/A Ra Capital Management, L.p. 0.00 -100.00
02-05 13G/A BlackRock, Inc. 6.70 39.87
11-14 13D/A Beehouse, LLC 0.03 -99.83
11-14 13G/A Price T Rowe Associates Inc /md/ 3.80 -33.36

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-07 10-Q The accompanying notes are an integral part of these unaudited condensed financial statements. The accompanying notes are an integral part of these unaudited condensed financial statements. The accompanying notes are an integral part of these unaudit
2025-03-10 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-08 1,231,468 2,613,251 47.12
2025-05-07 904,774 2,944,953 30.72
2025-05-06 979,262 2,378,249 41.18
2025-05-05 438,068 1,189,643 36.82

(click for more detail)

Similar Companies
TECH – Bio-Techne Corporation TERN – Terns Pharmaceuticals, Inc.
TLRY – Tilray Brands, Inc. TRML – Tourmaline Bio, Inc.
TSHA – Taysha Gene Therapies, Inc.


Financial data and stock pages provided by
Fintel.io